Logo image
Se connecter
Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical Trial
Article de revue   Avec comité de lecture

Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical Trial

Michail Ignatiadis, Andrew Bailey, Heather McArthur, Sarra El-abed, Evandro de Azambuja, Otto Metzger, Stephen Y. Chui, Max Dieterich, Thomas Perretti, Esther Shearer-Kang, …
JAMA : the journal of the American Medical Association, Vol.333(13), pp.1150-1160
01/04/2025
PMID: 39883436

Résumé

Online First Original Investigation
This randomized clinical trial investigates whether adding immune therapy to adjuvant chemotherapy for triple-negative breast cancer reduces recurrent disease.

Détails

Logo image